Clinics I work with
My reviews
4.8
I feel very lucky Dr. Rugo is my Oncologist. She is wise and compassionate I have total confidence in her.
Selected research
-
Most neoadjuvant chemotherapy for triple-negative breast cancer should include platinum.
The Lancet. Oncology
-
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Lancet (London, England)
-
A 4-Month Whole-Systems Ayurvedic Medicine Nutrition and Lifestyle Intervention Is Feasible and Acceptable for Breast Cancer Survivors: Results of a Single-Arm Pilot Clinical Trial.
Global advances in health and medicine
Clinical trials
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo...
The outcome measure of the study is IDFS, defined by the STEEP system as the first occurrence of the time from the date of randomization to the date of first invasive disease recurrence (local, regional or distant), the date of se...
Recruiting
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanc...
Progression Free Survival is defined from the time from randomization to the first occurrence of disease progression as determined by the investigator using RECIST 1.1 or death from any cause, whichever occurs first.
Recruiting
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Pr...
Assess the percentage of patients without disease progression based on local investigator assessment per RECIST in cohort A, cohort B and cohort C. Each cohort will be assessed when last patient in each cohort has reached 6 months...
Recruiting
Avelumab With Binimetinib, Utomilumab, or Anti-OX40 Antibody PF-04518600 in Treating Triple Neg...
Will be defined as the percentage of patients achieving complete response or partial response by RECIST version 1.1 and will be reported for each arm along with 95% two-sided confidence intervals.
Recruiting
Contact me
- Request appointment
- Refer a patient
- (415) 353-7070